Don’t miss our Advancing Healthcare Webinar Series presentation, Role of Biomarkers in the Cardiovascular Management of Patients with Cancer.
Renowned cardiologist Dr. Salim Hayek and will lead the discussion on how biomarkers can identify cardiovascular complications caused by cancer treatments, guide therapeutic strategies, and monitor patient responses.
Learning objectives
- Highlight case studies showcasing how biomarkers are utilized in cancer patient populations and explore ongoing research that promises to reveal new biomarkers and applications.
- Discuss the application of biomarkers in assessing the risk of cardiotoxicity, guiding therapy for heart failure, diagnosing, and managing immune-checkpoint myocarditis, along with a discussion on pitfalls and limitations.
- Underscore biomarkers' profound impact on improving cardiovascular outcomes in cancer patients and highlight the need for continued research and innovation in this emerging field.
Medical Director and Assistant Professor
University of Michigan Health – Michigan Medicine
Speakers
Salim Hayek, MD
Medical Director and Assistant Professor
University of Michigan Health – Michigan Medicine
Dr. Hayek is the Medical Director of the University of Michigan Frankel Cardiovascular Center Clinics, and a Cardiologist who specializes in Cardio-Oncology. While he sees patients with all types of heart disease, he has unique expertise in evaluating patients who are receiving or have completed cancer treatment to detect any signs of cardiovascular disease or complications early on. Dr. Hayek works closely with oncologists and healthcare providers to create personalized treatment plans that optimize the patient's overall health and minimize the risk of cardiovascular disease.
Dr. Hayek's approach to Cardio-Oncology is holistic and patient-centered. He focuses not only on the patient's cardiovascular health but also on their overall well-being, taking into account their unique medical history, cancer treatment plan, and personal goals. By working with patients to prevent and manage cardiovascular complications related to cancer treatment, Dr. Hayek helps to ensure that patients can not only fight cancer but also maintain good heart health and quality of life.
He has received many accolades and awards for both excellence in patient care and his contributions to science. Dr. Hayek is a prolific researcher, authoring over 160 peer-reviewed publications, many in the highest impact journals such as the New England Journal of Medicine, Nature Medicine, The Journal of Clinical Investigation, Circulation, JACC and others. His contributions have been recognized through prestigious awards, including the American College of Cardiology Douglas P. Zipes Distinguished Young Scientist award, American Heart Association Samuel Levine Early Career Investigator award, Juanita L. Merchant Early Career Endowment award and the Jerome W.p Conn Award for Excellence in Research.
Senior Clinical Consultant
Siemens Healthineers
Moderator: Dr. Jim Aguanno, Ph.D.
Senior Clinical Consultant
Siemens Healthineers
Dr. Jim Aguanno has over 40 years of experience in laboratory medicine. He received a Bachelor of Science in Chemistry and a Ph.D. in Biochemistry from Memphis State University. Following his Ph.D., he did two post-doctoral fellowships one at the University of Pittsburgh School of Medicine in Biochemistry and a second fellowship in Laboratory Medicine at Washington University School of Medicine and Barnes Hospital in St. Louis, Missouri. Dr. Aguanno was Director of the Core Laboratory at Baylor University Medical Center in Dallas, Texas for 24 years. Dr. Aguanno joined Siemens Healthineers in January of 2004 and is currently Senior Clinical Consultant in the Clinical and Scientific Affairs group focusing on cardiovascular disease, infectious diseases and general aspects of laboratory medicine.
